Acro Biomedical CoACBM Gross Margin % is 0.00% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 73 Diversified Financial Services companies, Acro Biomedical Co ranks worse than 1369861.64% on this metric.
The historical rank and industry rank for Acro Biomedical Co's Gross Margin % or its related term are showing as below:
During the past 11 years, the highestGross Margin % of Acro Biomedical Co was 23.11%. The lowest was 9.97%. And the median was 15.90%.
ACBM's Gross Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 42.14 * Ranked among companies with meaningful Gross Margin % only.
Acro Biomedical Co had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Acro Biomedical Co was 0.00% per year.
Acro Biomedical Co (OTCPK:ACBM) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Acro Biomedical Co had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Acro Biomedical Co Gross Margin % Related Terms
Acro Biomedical Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Acro Biomedical Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACBM vs RNGC, EEGI, GMZP: Gross Margin % Comparison
For the Shell Companies subindustry, Acro Biomedical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acro Biomedical Co Gross Margin % vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Acro Biomedical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Acro Biomedical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Acro Biomedical Co (ACBM) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Acro Biomedical Co and its competitors. Over the past decade, Acro Biomedical Co's Gross Margin % has ranged from 9.97 to 23.11. According to the industry distribution chart, Acro Biomedical Co ranks #999999 out of 73 companies in the Diversified Financial Services industry.
Is Acro Biomedical Co's Gross Margin % too high?
Acro Biomedical Co's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 9.97 to a high of 23.11. Based on the distribution chart, Acro Biomedical Co ranks #999999 out of 73 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers.
How does Acro Biomedical Co's Gross Margin % compare to RNGC and EEGI?
According to the Diversified Financial Services industry distribution chart, Acro Biomedical Co ranks #999999 out of 73 companies for Gross Margin %. This places Acro Biomedical Co in the lower half of its industry. The industry median Gross Margin % is 42.14. Historically, Acro Biomedical Co's own Gross Margin % has ranged from 9.97 to 23.11 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Diversified Financial Services company?
The median Gross Margin % among Diversified Financial Services companies is 42.14, based on 73 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Acro Biomedical Co and its competitors. For the Diversified Financial Services industry, the median Gross Margin % is 42.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acro Biomedical Co's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Acro Biomedical Co (ACBM) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Acro Biomedical Co (ACBM), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACBM has been successfully added to your 